KAPITTEL 6
Referanser

Aaseth K, Grande RB, Kvaerner KJ, Gulbrandsen P, Lundqvist C, Russell MB. Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia 2008;28(7):705-13. [Pubmed]

AGS Beers criteria for potentially inappropriate medication use in older adults American Geriatrics Society [oppdatert 2012; lest Jun 2013]. [Lenke]

Andersen EJ. Hva kan legene gjøre selv? Tidsskr Nor Legeforen 2007;127(24):3308-9. [Lenke]

Ashton CH. Benzodiazepiner. Hvordan de virker og hvordan man nedtrapper: medicinsk forskningsinformation fra en nedtrapningsklinik for benzodiazepiner. Newcastle upon Tyne: Royal Victoria Infirmary, Department of Psychiatry; 2002. [Lenke]

Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 2012;16(2):77-84. [Pubmed]

Bell CM, Fischer HD, Gill SS, Zagorski B, Sykora K, Wodchis WP, et al. Initiation of benzodiazepines in the elderly after hospitalization. J Gen Intern Med 2007;22(7):1024-9. [Pubmed]

Benzodiazepiner og graviditet (spm. nr. 3851) [database]. RELIS database [oppdatert 12 Nov 2009; lest Mar 2012] [Lenke]

Berg C, Sakshaug S, Handal M, Skurtveit S. Z-hypnotika – Sovemidlene som dominerer markedet i Norge. Norsk Farmaceutisk Tidsskrift 2011;119(4):20-3. [Lenke]

Billioti de GS, Begaud B, Bazin F, Verdoux H, Dartigues JF, Peres K, et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ 2012;345:e6231. [Lenke]

Bjørner T, Tvete IF, Aursnes I, Skomedal T. Utlevering av benzodiazepiner og z-hypnotika fra norske apotek 2004-11. Tidsskr Nor Legeforen 2013;133(20):2149-53. [Lenke]

Bloor M, Paech MJ, Kaye R. Tramadol in pregnancy and lactation. Int J Obstet Anesth 2012;21(2):163-7. [Pubmed]

Bracken MB, Holford TR. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 1981;58(3):336-44. [Pubmed]

Bramness JG, Rossow I. Can the total consumption of a medicinal drug be used as an indicator of excessive use? The case of carisoprodol. Drugs (Abingdon Engl) 2010;17(2):168-80. 80. [Lenke]

Bramness JG, Sexton JA. The basic pharmacoepidemiology of benzodiazepine use in Norway 2004-9. Norsk Epidemiologi 2011;21(1):35-42. [Lenke]

Bramness JG. Misbruk av pregabalin. Tidsskr Nor Legeforen 2010;130(17):1703-4. [Lenke]

Brekke M, Rognstad S, Straand J, Furu K, Gjelstad S, Bjorner T, et al. Pharmacologically inappropriate prescriptions for elderly patients in general practice: How common? Baseline data from The Prescription Peer Academic Detailing (Rx-PAD) study. Scand J Prim Health Care 2008;26(2):80-5. [Pubmed]

Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 9 utg. Philadelphia, Pa: Lippincot Williams & Wilkins; 2011.

Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011;204(4):314-11. [Lenke]

Brunton LL, Paker KL, red. Goodman & Gilman's manual of pharmacology and therapeutics. New York: McGraw Hill Medical; 2008.

Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J, et al. Maternal medication use and neuroblastoma in offspring. Am J Epidemiol 2004;159(8):721-31. [Pubmed]

Dassanayake T, Michie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf 2011;34(2):125-56. [Pubmed]

Diav-Citrin O, Okotore B, Lucarelli K, Koren G. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study. Am J Perinatol 1999;16(4):157-60. [Pubmed]

Den norske legeforening. Retningslinjer for smertelindring 2009. [Lenke]

Den norske legeforening. Villa Sana [nettdokument]. [oppdatert 30 Sep 2008; lest Jun 2013]. [Lenke]

Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004;3(8):475-83. [Pubmed]

Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 1998;317(7162):839-43. [Pubmed]

Dow K, Ordean A, Murphy-Oikonen J, Pereira J, Koren G, Roukema H, et al. Neonatal abstinence syndrome clinical practice guidelines for Ontario. J Popul Ther Clin Pharmacol 2012;19(3):e488-e506. [Pubmed]

Elvik R. Risk of road accident associated with the use of drugs: A systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev 2013; 60: 254-67. [Pubmed]

Evans A. Dopamine agonist-induced substance addiction: The next piece of the puzzle. J Clin Neurosci 2011;18(2):191-2. [Pubmed]

Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 2010; 9(4):391-401. [Pubmed]

Evers S, Jensen R. Treatment of medication overuse headache--guideline of the EFNS headache panel. Eur J Neurol 2011;18(9):1115-21. [Pubmed]

Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163(22):2716-24. [Pubmed]

Forskrift om rekvirering og utlevering av legemidler fra apotek. FOR 2013-02-14-242. [Lenke]

Greenblatt DJ, Roth T. Zolpidem for insomnia. Expert Opin Pharmacother 2012;13(6):879-93. [Pubmed]

Grande RB, Aaseth K, Benth JS, Lundqvist C, Russell MB. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol 2011;18(1):129-37. [Pubmed]

Grande RB, Aaseth K, Gulbrandsen P, Lundqvist C, Russell MB. Prevalence of primary chronic headache in a population-based sample of 30- to 44-year-old persons. The Akershus study of chronic headache. Neuroepidemiology 2008;30(2):76-83. [Pubmed]

Hale TW. Medication and mothers milk: a manual of lactational pharmacology. 15 utg. Amarillo, TX: Hale Publications; 2012.

Handal M, Engeland A, Ronning M, Skurtveit S, Furu K. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. Eur J Clin Pharmacol 2011;67(9):953-60. [Pubmed]

Handal M, Skurtveit S, Mørland JG. Samtidig bruk av ulike benzodiazepiner. Tidsskr Nor Legeforen 2012;132(5):526-30. [Lenke]

Hartz I, Furu K, Bratlid T, Handal M, Skurtveit S. Hypnotic drug use among 0-17 year olds during 2004-2011: a nationwide prescription database study. Scand J Public Health 2012;40(8):704-11. [Pubmed]

Hartz I, Tverdal A, Skille E, Skurtveit S. Disability pension as predictor of later use of benzodiazepines among benzodiazepine users. Soc Sci Med 2010;70(6):921-5. [Pubmed]

Hartz I, Tverdal Aa, Skurtveit S. Langtidsbruk av BZD i kombinasjon med opioider og z-hypnotika blant uføretrygdede i Norge. Norsk Farmaceutisk Tidsskrift 2011;119(4):20-3. [Lenke]

Haugli A, Janbu T, Hansen T-E, Nesje LA. Allmennmedisinske utfordringer: sikkerhet på legekontoret - hvordan skal vi forholde oss? Utposten 2010;39(7):2-7. [Lenke]

Helsedirektoratet. Nasjonal retningslinje for gravide i legemiddelassistert rehabilitering (LAR) og oppfølging av familien frem til barnet når skolealder. Oslo: Helsedirektoratet; 2011. IS-1876. [Lenke]

Helsedirektoratet. Nasjonal retningslinje for legemiddelassistert rehabilitering ved opioidavhengighet. Oslo: Helsedirektoratet; 2010. IS-1701. [Lenke]

Helsedirektoratet. Helsepersonelloven med kommentarer. Oslo: Helsedirektoratet; 06/2012. Rundskriv IS-8/2012. [Lenke]

Helsedirektoratet. Veileder i forskrivning av vanedannende legemidler. Oslo: Helsedirektoratet; 1990. Helsedirektoratets veiledningsserie; 2:90.

Helsedirektoratet. Veileder til forskrift om helsekrav for personer i arbeid på innretninger i petroleumsvirksomhetene til havs. Oslo: Helsedirektoratet; 2011. IS-1879. [Lenke]

Helse- og omsorgsdepartementet. Prop. 1 S (2010-2011): proposisjon til Stortinget (forslag til storingsvedtak) for budsjettåret 2011. [Lenke]

Hendrickson RG, McKeown NJ. Is maternal opioid use hazardous to breast-fed infants? Clin Toxicol (Phila) 2012;50(1):1-14. [Pubmed]

Hernandez TD, Heninger C, Wilson MA, Gallager DW. Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure. Eur J Pharmacol 1989;170(3):145-55. [Pubmed]

ICD 10. F10-F19.1 Psykiske lidelser og atferdsforstyrrelser som skyldes bruk av psykoaktive stoffer. Skadelig bruk [nettsted]. Helsedirektoratet; KITH(10. revisjon): [oppdatert 2013; lest Jun 2014]. [Lenke]

ICD 10. F10-F19.2 Psykiske lidelser og atferdsforstyrrelser som skyldes bruk av psykoaktive stoffer. Avhengighetssyndrom [nettsted]. Helsedirektoratet; KITH(10. revisjon): [oppdatert 2013; lest Jun 2014]. [Lenke]

ICD 10. F10-F19.4 Psykiske lidelser og atferdsforstyrrelser som skyldes bruk av psykoaktive stoffer. Abstinenstilstand med delirium [nettsted]. Helsedirektoratet; KITH(10. revisjon): [oppdatert 2013; lest Jun 2014]. [Lenke]

Ilett KF, Paech MJ, Page-Sharp M, Sy SK, Kristensen JH, Goy R, et al. Use of a sparse sampling study design to assess transfer of tramadol and its O-desmethyl metabolite into transitional breast milk. Br J Clin Pharmacol 2008;65(5):661-6.

Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2009;(3):CD005170. [Pubmed]

Janusinfo, Stockholms läns landsting. Läkemedel och amming [nettdokument/database] [oppdatert 2013; lest Mar 2012]. [Lenke]

Janusinfo, Stockholms läns landsting. Läkemedel och fosterpåverkan [nettdokument/database]. [oppdatert 2013; lest Mar 2012]. [Lenke]

Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol 2007;20(3):326-30. [Pubmed]

Kjosavik SR, Ruths S, Hunskaar S. Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway. Eur J Clin Pharmacol 2012;68(3):311-9. [Pubmed]

Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006;368(9536):704. [Pubmed]

Kristoffersen ES, Grande RB, Aaseth K, Lundqvist C, Russell MB. Management of primary chronic headache in the general population: the Akershus study of chronic headache. J Headache Pain 2012;13(2):113-20. [Pubmed]

Lader M. Benzodiazepines revisited–will we ever learn? Addiction 2011;106(12):2086-109. [Pubmed]

Laegreid L, Hagberg G, Lundberg A. The effect of benzodiaze11pines on the fetus and the newborn. Neuropediatrics 1992;23(1):18-23. [Pubmed]

Madadi P, Shirazi F, Walter FG, Koren G. Establishing causality of CNS depression in breastfed infants following maternal codeine use. Paediatr Drugs 2008;10(6):399-404. [Pubmed]

Mangurten HH, Benawra R. Neonatal codeine withdrawal in infants of nonaddicted mothers. Pediatrics 1980;65(1):159-60. [Pubmed]

McIntosh B, Clark M, Spry C. Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2011. [Lenke]

Mellbye A, Svendsen K, Borchgrevink PC, Skurtveit S, Fredheim OM. Concomitant medication among persistent opioid users with chronic non-malignant pain. Acta Anaesthesiol Scand 2012;56(10):1267-76. [Pubmed]

Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006;46(5):766-72. [Pubmed]

Mouland G. Brev til brukere av benzodiazepiner - en effektiv måte å få ned forskrivningen på. Tidsskr Nor Legeforen 1997;117(21):3097-100.

Mugunthan K, McGuire T, Glasziou P. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Br J Gen Pract 2011;61(590):e573-e578. [Pubmed]

Mørland JG. Interaksjoner mellom legemidler og alkohol. Tidsskr Nor Legeforen 2002;122(5):511-3. [Lenke]

Nardi AE, Machado S, Almada LF, Paes F, Silva AC, Marques RJ, et al. Clonazepam for the treatment of panic disorder. Curr Drug Targets 2013;14(3):353-64. [Pubmed]

Nasjonal kompetanetjeneste for søvnsykdommer - SOVno. Bergen: Helse Bergen, Haukeland universitetssjukehus; 2010. [Lenke]

Nasjonalt kunnskapssenter for helsetjenesten. Benzodiazepiner i behandling av personer med rusmiddelproblemer; 2007. Rapport 2007:6. [Lenke]

Nasjonalt kunnskapssenter for helsetjenesten. Sakte, men sikker avslutning av benzodiazepiner (omtale av oversikt) [oppdatert 10 Feb 2010; lest Jun 2013]. [Lenke]

Neutel CI, Skurtveit S, Berg C. Benzodiazepine and z-hypnotic use in Norwegian elderly, aged 65-79. Norsk Epidemiologi 2012;22(2):203-8. [Lenke]

Neutel CI, Skurtveit S, Berg C. Polypharmacy of potentially addictive medication in the older persons--quantifying usage. Pharmacoepidemiol Drug Saf 2012;21(2):199-206. [Pubmed]

Neutel CI, Skurtveit S, Berg C. What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population. Sleep Med 2012;13(7):893-7. [Pubmed]

Nielsen M, Hansen EH, Gotzsche PC. Dependence and withdrawal reactions to benzodiazepines and selective serotonin reuptake inhibitors. How did the health authorities react? Int J Risk Saf Med 2013;25(3):155-68. [Pubmed]

Norsk legemiddelhåndbok. Benzodiazepiner. Foreningen for utgivelse av Norsk legemiddelhåndbok; 2013. [Lenke]

Norsk legemiddelhåndbok. Oslo: Foreningen for utgivelse av Norsk legemiddelhåndbok; 2013. [Lenke]

Pedersen W, Lavik NJ. Adolescents and benzodiazepines: prescribed use, self-medication and intoxication. Acta Psychiatr Scand 1991;84(1):94-8. [Lenke]

Politiet. Narkotikastatistikk 2012 [nettside]. [oppdatert 23 Jan 2013; lest Jun 2013]. [Lenke]

Ranhoff AH, Brørs O. Legemidler som kan gi delerium hos eldre. Tidsskr Nor Legeforen 2005;125(17):2366-7. [Lenke]

Reseptregisteret [nettsted]. Oslo: Nasjonalt folkehelseinstitutt [oppdatert Mar 2013; lest Jun 2013]. [Lenke]

Reynolds EW, Riel-Romero RM, Bada HS. Neonatal abstinence syndrome and cerebral infarction following maternal codeine use during pregnancy. Clin Pediatr (Phila) 2007;46(7):639-45. [Pubmed]

Rossi P, Faroni JV, Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol 2011;18(3):396-401. [Pubmed]

Rossi P, Jensen R, Nappi G, Allena M. A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 2009;10(6):407-17. [Pubmed]

Rønning M, Berg C, Furu K, Litleskare I, Sakshaug S, Selmer R, et al. Reseptregisteret 2005–2009. Oslo: Folkehelseinstituttet; 2010. Legemiddelstatistikk 2010:2. [Lenke]

Saxen I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975;4(1):37-44. [Pubmed]

Schaefer C, Peters P, Miller RK, red. Drugs during pregnancy and lactation: treatment option and risk assessment. 2 utg. Amsterdam: Elsevier; 2007.

SINTEF. Bruk av vanedannende legemidler i Norge: i befolkningen generelt, og blant pasienter utskrevet fra sykehus. Oslo; Trondheim: SINTEF Teknologi og samfunn, Helse; 2011. SINTEF A21453. [Lenke]

Skurtveit S, Furu K, Bramness J, Selmer R, Tverdal A. Benzodiazepines predict use of opioids--a follow-up study of 17,074 men and women. Pain Med 2010;11(6):805-14. [Pubmed]

Straand J. To prescribe or not to prescribe. Drug prescribing studies from general practice. The Møre & Romsdal Prescription Study (II). Nor J Epidemiol 1999;9(Suppl 2). [Lenke]

Statens Helsetilsyn. Veileder for fylkesmannen i behandling av rekvireringssaker. Oslo: Statens helsetilsyn; 2016. Internserie 2016. [Lenke]

Statens legemiddelverk. Legemiddelsøk (Interaksjonssøk) [database]. [oppdatert 2013; lest Jun 2013]. [Lenke]

Sunhedsstyrelsen. Vejledning om ordination af afhængighedsskabende lægemidler. København: Sunhedsstyrelsen; 2008. Vejledning 2008:38. [Lenke]

Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 2003;26(4):261-82. [Pubmed]

The American Geriatrics Society (AGS) [nettsted]. [oppdatert 2013; lest Jun 2013]. [Lenke]

The International Classification of Headache Disorders: 3rd edition (beta version). Cephalalgia 2013;33:629-808. [Pubmed]

Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev 2000;4(6):551-81. [Pubmed]

Webster LR. Considering the risks of benzodiazepines and opioids together. Pain Med 2010;11(6):801-2. [Pubmed]

Welsh Medicines Partnership. Educational pack. Material to support appropriate prescribing of hypnotics and anxiolytics across Wales. Wales: NHS Wales; 2011. [Lenke]

Wikner BN, Kallen B. Are hypnotic benzodiazepine receptor agonists teratogenic in humans? J Clin Psychopharmacol 2011;31(3):356-9. [Pubmed]

Wikner BN, Stiller CO, Bergman U, Asker C, Kallen B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 2007;16(11):1203-10. [Pubmed]

Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006;66(12):1894-8. [Lenke]

Først publisert: 12. desember 2015 Sist faglig oppdatert: 01. februar 2017